Michael Recht

7.8k total citations
140 papers, 2.6k citations indexed

About

Michael Recht is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Michael Recht has authored 140 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Hematology, 29 papers in Genetics and 24 papers in Molecular Biology. Recurrent topics in Michael Recht's work include Hemophilia Treatment and Research (108 papers), Platelet Disorders and Treatments (32 papers) and Blood Coagulation and Thrombosis Mechanisms (26 papers). Michael Recht is often cited by papers focused on Hemophilia Treatment and Research (108 papers), Platelet Disorders and Treatments (32 papers) and Blood Coagulation and Thrombosis Mechanisms (26 papers). Michael Recht collaborates with scholars based in United States, Italy and Germany. Michael Recht's co-authors include E. Knight, Ernest C. Borden, David L. Cooper, Robert Gut, Kristina M. Haley, Susan Lattimore, Michelle Witkop, Trisha E. Wong, Christine L. Kempton and Michael Wang and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael Recht

132 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Recht United States 29 1.9k 483 426 403 400 140 2.6k
Carmem Bonfim Brazil 24 925 0.5× 472 1.0× 248 0.6× 218 0.5× 454 1.1× 146 1.9k
William B. Slayton United States 23 941 0.5× 455 0.9× 270 0.6× 213 0.5× 474 1.2× 83 2.1k
Biljana Horn United States 29 735 0.4× 378 0.8× 490 1.2× 185 0.5× 305 0.8× 84 2.0k
J M Chessells United Kingdom 29 1.3k 0.7× 398 0.8× 391 0.9× 205 0.5× 315 0.8× 62 2.5k
Marrie C.A. Bruin Netherlands 24 1.0k 0.5× 255 0.5× 198 0.5× 279 0.7× 199 0.5× 51 1.9k
Masue Imaizumi Japan 25 818 0.4× 886 1.8× 205 0.5× 220 0.5× 279 0.7× 101 2.0k
Alicia Rovó Switzerland 23 966 0.5× 204 0.4× 264 0.6× 75 0.2× 401 1.0× 109 1.7k
Judith M. Chessells United Kingdom 35 2.1k 1.1× 589 1.2× 656 1.5× 404 1.0× 459 1.1× 91 3.8k
Joanne Kurtzberg United States 25 673 0.4× 461 1.0× 484 1.1× 157 0.4× 336 0.8× 73 2.1k
W. Lange Germany 24 599 0.3× 514 1.1× 383 0.9× 179 0.4× 812 2.0× 59 1.9k

Countries citing papers authored by Michael Recht

Since Specialization
Citations

This map shows the geographic impact of Michael Recht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Recht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Recht more than expected).

Fields of papers citing papers by Michael Recht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Recht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Recht. The network helps show where Michael Recht may publish in the future.

Co-authorship network of co-authors of Michael Recht

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Recht. A scholar is included among the top collaborators of Michael Recht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Recht. Michael Recht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berger, Jeffrey S., Eduardo Iturrate, Malte Westerhoff, et al.. (2025). Opportunistic assessment of abdominal aortic calcification using artificial intelligence (AI) predicts coronary artery disease and cardiovascular events. American Heart Journal. 288. 122–130.
2.
Valentino, Leonard A., et al.. (2025). Contemporary approaches to treat people with hemophilia: what’s new and what’s not?. Research and Practice in Thrombosis and Haemostasis. 9(1). 102696–102696. 1 indexed citations
3.
Pipe, Steven W., Wolfgang Miesbach, Michael Recht, et al.. (2025). Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B. New England Journal of Medicine. 394(5). 463–474.
4.
Itzler, Robbin, Tyler W. Buckner, Frank W.G. Leebeek, et al.. (2024). Effect of etranacogene dezaparvovec on quality of life for severe and moderately severe haemophilia B participants: Results from the phase III HOPE‐B trial 2 years after gene therapy. Haemophilia. 30(3). 709–719. 5 indexed citations
5.
Chandler, Martin, et al.. (2024). Effectiveness of Damoctocog Alfa Pegol to Treat Patients With Hemophilia A Enrolled in the ATHNdataset. European Journal Of Haematology. 114(3). 448–457.
6.
Batsuli, Glaivy, Suchitra Acharya, Osman Khan, et al.. (2024). Real‐world effectiveness of eptacog beta in patients with haemophilia and inhibitors: A multi‐institutional case series. Haemophilia. 30(6). 1321–1331. 1 indexed citations
7.
Ragni, Margaret V., J. B. Callis, Jonathan P. Schwartz, et al.. (2023). Observational cohort study of long‐term outcomes of liver transplantation in haemophilia. Haemophilia. 30(1). 87–97. 1 indexed citations
8.
Corrales‐Medina, Fernando F., et al.. (2023). Direct oral anticoagulants in pediatric venous thromboembolism: Experience in specialized pediatric hemostasis centers in the United States. Research and Practice in Thrombosis and Haemostasis. 7(1). 100001–100001. 6 indexed citations
9.
Valentino, Leonard A., et al.. (2023). The National Hemophilia Foundation State of the Science Research Summit initiative: executive summary. Expert Review of Hematology. 16(sup1). 129–134. 4 indexed citations
10.
11.
Johnsen, Jill M., Beth Martin, Martin Kircher, et al.. (2022). Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United States. Journal of Thrombosis and Haemostasis. 20(9). 2022–2034. 16 indexed citations
12.
Valentino, Leonard A., et al.. (2022). Building the blueprint: Formulating a community‐generated national plan for future research in inherited bleeding disorders. Haemophilia. 28(5). 760–768. 7 indexed citations
13.
Witkop, Michelle, et al.. (2021). Impact of haemophilia on patients with mild‐to‐moderate disease: Results from the P‐FiQ and B‐HERO‐S studies. Haemophilia. 27(S1). 8–16. 13 indexed citations
14.
Li, Nanxin, Eileen K. Sawyer, Gregory F. Guzauskas, et al.. (2021). Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic model. Journal of Medical Economics. 24(1). 363–372. 8 indexed citations
15.
16.
Malec, Lynn, Dunlei Cheng, Char Witmer, et al.. (2020). The impact of extended half‐life factor concentrates on prophylaxis for severe hemophilia in the United States. American Journal of Hematology. 95(8). 960–965. 22 indexed citations
17.
Eriksson, Carl, et al.. (2019). Delirium in the pediatric hematology, oncology, and bone marrow transplant population. Pediatric Blood & Cancer. 66(6). e27640–e27640. 14 indexed citations
18.
19.
20.
Manco‐Johnson, Marilyn J., M L Manco-Johnson, Sharon Funk, et al.. (2013). Long-Term Orthopedic Effects Of Delaying Prophylaxis In Severe Hemophilia A Until Age 6 Years: Results Of The Joint Outcome Study Continuation (JOSc). Blood. 122(21). 210–210. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmem Bonfim Breakdown of academic impact, for papers by William B. Slayton Breakdown of academic impact, for papers by Biljana Horn Breakdown of academic impact, for papers by J M Chessells Breakdown of academic impact, for papers by Marrie C.A. Bruin Breakdown of academic impact, for papers by Masue Imaizumi Breakdown of academic impact, for papers by Alicia Rovó Breakdown of academic impact, for papers by Judith M. Chessells Breakdown of academic impact, for papers by Joanne Kurtzberg Breakdown of academic impact, for papers by W. Lange
Rankless by CCL
2026